Global Seasonal Affective Disorder Drugs Market Insights, Research Forecast to 2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 116

Report ID: 5371

Seasonal affective disorder or SAD is a recurrent major depressive disorder with a seasonal pattern usually beginning in fall and continuing into winter months.
The global Seasonal Affective Disorder Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Seasonal Affective Disorder Drugs market based on company, product type, end user and key regions.

This report studies the global market size of Seasonal Affective Disorder Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Seasonal Affective Disorder Drugs in these regions.
This research report categorizes the global Seasonal Affective Disorder Drugs market by top players/brands, region, type and end user. This report also studies the global Seasonal Affective Disorder Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer
GlaxoSmithKline
Bristol-Myers Squibb
Otsuka Pharmaceutical
Mylan
Merck

Market size by Product
SSRIs
SNRIs
NDRIs
TCAs
MOAIs
Market size by End User
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Seasonal Affective Disorder Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Seasonal Affective Disorder Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Seasonal Affective Disorder Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Seasonal Affective Disorder Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Seasonal Affective Disorder Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Seasonal Affective Disorder Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Seasonal Affective Disorder Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Seasonal Affective Disorder Drugs Market Size Growth Rate by Product
1.4.2 SSRIs
1.4.3 SNRIs
1.4.4 NDRIs
1.4.5 TCAs
1.4.6 MOAIs
1.5 Market by End User
1.5.1 Global Seasonal Affective Disorder Drugs Market Size Growth Rate by End User
1.5.2 Hospital Pharmacies
1.5.3 Online Pharmacies
1.5.4 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Seasonal Affective Disorder Drugs Market Size
2.1.1 Global Seasonal Affective Disorder Drugs Revenue 2014-2025
2.1.2 Global Seasonal Affective Disorder Drugs Sales 2014-2025
2.2 Seasonal Affective Disorder Drugs Growth Rate by Regions
2.2.1 Global Seasonal Affective Disorder Drugs Sales by Regions
2.2.2 Global Seasonal Affective Disorder Drugs Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Seasonal Affective Disorder Drugs Sales by Manufacturers
3.1.1 Seasonal Affective Disorder Drugs Sales by Manufacturers
3.1.2 Seasonal Affective Disorder Drugs Sales Market Share by Manufacturers
3.1.3 Global Seasonal Affective Disorder Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Seasonal Affective Disorder Drugs Revenue by Manufacturers
3.2.1 Seasonal Affective Disorder Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Seasonal Affective Disorder Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Seasonal Affective Disorder Drugs Price by Manufacturers
3.4 Seasonal Affective Disorder Drugs Manufacturing Base Distribution, Product Types
3.4.1 Seasonal Affective Disorder Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Seasonal Affective Disorder Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Seasonal Affective Disorder Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Seasonal Affective Disorder Drugs Sales by Product
4.2 Global Seasonal Affective Disorder Drugs Revenue by Product
4.3 Seasonal Affective Disorder Drugs Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Seasonal Affective Disorder Drugs Breakdown Data by End User

6 North America
6.1 North America Seasonal Affective Disorder Drugs by Countries
6.1.1 North America Seasonal Affective Disorder Drugs Sales by Countries
6.1.2 North America Seasonal Affective Disorder Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Seasonal Affective Disorder Drugs by Product
6.3 North America Seasonal Affective Disorder Drugs by End User

7 Europe
7.1 Europe Seasonal Affective Disorder Drugs by Countries
7.1.1 Europe Seasonal Affective Disorder Drugs Sales by Countries
7.1.2 Europe Seasonal Affective Disorder Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Seasonal Affective Disorder Drugs by Product
7.3 Europe Seasonal Affective Disorder Drugs by End User

8 Asia Pacific
8.1 Asia Pacific Seasonal Affective Disorder Drugs by Countries
8.1.1 Asia Pacific Seasonal Affective Disorder Drugs Sales by Countries
8.1.2 Asia Pacific Seasonal Affective Disorder Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Seasonal Affective Disorder Drugs by Product
8.3 Asia Pacific Seasonal Affective Disorder Drugs by End User

9 Central & South America
9.1 Central & South America Seasonal Affective Disorder Drugs by Countries
9.1.1 Central & South America Seasonal Affective Disorder Drugs Sales by Countries
9.1.2 Central & South America Seasonal Affective Disorder Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Seasonal Affective Disorder Drugs by Product
9.3 Central & South America Seasonal Affective Disorder Drugs by End User

10 Middle East and Africa
10.1 Middle East and Africa Seasonal Affective Disorder Drugs by Countries
10.1.1 Middle East and Africa Seasonal Affective Disorder Drugs Sales by Countries
10.1.2 Middle East and Africa Seasonal Affective Disorder Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Seasonal Affective Disorder Drugs by Product
10.3 Middle East and Africa Seasonal Affective Disorder Drugs by End User

11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Business Overview
11.1.3 Pfizer Seasonal Affective Disorder Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Pfizer Seasonal Affective Disorder Drugs Products Offered
11.1.5 Pfizer Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 Company Business Overview
11.2.3 GlaxoSmithKline Seasonal Affective Disorder Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 GlaxoSmithKline Seasonal Affective Disorder Drugs Products Offered
11.2.5 GlaxoSmithKline Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Company Business Overview
11.3.3 Bristol-Myers Squibb Seasonal Affective Disorder Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Bristol-Myers Squibb Seasonal Affective Disorder Drugs Products Offered
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Otsuka Pharmaceutical
11.4.1 Otsuka Pharmaceutical Company Details
11.4.2 Company Business Overview
11.4.3 Otsuka Pharmaceutical Seasonal Affective Disorder Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Otsuka Pharmaceutical Seasonal Affective Disorder Drugs Products Offered
11.4.5 Otsuka Pharmaceutical Recent Development
11.5 Mylan
11.5.1 Mylan Company Details
11.5.2 Company Business Overview
11.5.3 Mylan Seasonal Affective Disorder Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Mylan Seasonal Affective Disorder Drugs Products Offered
11.5.5 Mylan Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Company Business Overview
11.6.3 Merck Seasonal Affective Disorder Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Merck Seasonal Affective Disorder Drugs Products Offered
11.6.5 Merck Recent Development

12 Future Forecast
12.1 Seasonal Affective Disorder Drugs Market Forecast by Regions
12.1.1 Global Seasonal Affective Disorder Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Seasonal Affective Disorder Drugs Revenue Forecast by Regions 2019-2025
12.2 Seasonal Affective Disorder Drugs Market Forecast by Product
12.2.1 Global Seasonal Affective Disorder Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Seasonal Affective Disorder Drugs Revenue Forecast by Product 2019-2025
12.3 Seasonal Affective Disorder Drugs Market Forecast by End User
12.4 North America Seasonal Affective Disorder Drugs Forecast
12.5 Europe Seasonal Affective Disorder Drugs Forecast
12.6 Asia Pacific Seasonal Affective Disorder Drugs Forecast
12.7 Central & South America Seasonal Affective Disorder Drugs Forecast
12.8 Middle East and Africa Seasonal Affective Disorder Drugs Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Seasonal Affective Disorder Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer